ISRCTN ISRCTN53383289
DOI https://doi.org/10.1186/ISRCTN53383289
Secondary identifying numbers 3
Submission date
31/10/2007
Registration date
06/11/2007
Last edited
31/12/2020
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Circulatory System
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Prof Hans Wilhelm Hoepp
Scientific

Kerpener Str. 62
Cologne
50937
Germany

Email hw.hoepp@uni-koeln.de

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Not specified
Study typeQuality of life
Scientific titleHypertension Evaluation Project III
Study acronymHEP III
Study objectivesInnovative ways for dissemination of guidelines are superior to traditional ways.
Ethics approval(s)All participants took part voluntarily and the interventions were optional therefore ethics approval was not necessary.
Health condition(s) or problem(s) studiedHypertension
Intervention1. Guideline in print
2. Interactive guideline
3. Expert seminars
4. Control group

The intervention groups were 3825 physicians for the expert seminars and always 1500 for the guideline in print, the interactive guideline and the control group. The medium follow-up time after intervention was approximately six months.
Intervention typeOther
Primary outcome measureDifference in guideline awareness between trained physicians and the control group.
Secondary outcome measuresOverall guideline awareness.
Overall study start date01/01/2004
Completion date31/03/2005

Eligibility

Participant type(s)Patient
Age groupAdult
SexBoth
Target number of participants8325
Total final enrolment3825
Key inclusion criteriaParticipants of HEP I-trial: In the HEP-I trial we explored the guideline awareness of 24899 German physicians, including all internists, cardiologists and 22% of general practitioners in a nationwide survey. The data is already published (see http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=11677375)
Key exclusion criteriaSee inclusion criteria.
Date of first enrolment01/01/2004
Date of final enrolment31/03/2005

Locations

Countries of recruitment

  • Germany

Study participating centre

Kerpener Str. 62
Cologne
50937
Germany

Sponsor information

University of Cologne (Germany)
University/education

Koeln Fortune Program
Faculty of Medicine
Kerpener Str. 62
Cologne
50937
Germany

Email t.hensler@uni-koeln.de
Website http://www.uni-koeln.de/index.e.html
ROR logo "ROR" https://ror.org/00rcxh774

Funders

Funder type

University/education

University of Cologne (Germany) - Koeln Fortune Program, Faculty of Medicine

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 25/06/2008 31/12/2020 Yes No

Editorial Notes

31/12/2020: The following changes have been made:
1. Publication reference added.
2. The final enrolment number has been added from the reference.